Can CAR T cell therapy be used to fight prostate cancer? – Cancer Research Institute
Cancer Research Institute shared a report by Charlie Schmidt on LinkedIn:
“Can CAR T cell therapy be used to fight prostate cancer?
In a new phase 1 trial, investigators treated 14 metastatic prostate cancer patients who no longer responded to hormonal therapy with 100 million CAR T cells, either with or without lymphodepletion. “Results were encouraging,” Harvard Health Publishing describes, suggesting that CAR T cell therapy “may emerge as an additional immunotherapeutic option for men with prostate cancer.”
Quoting on Charlie Schmidt’s report:
Tittle: CAR-T immunotherapy for prostate cancer? Early clinical trial results suggest new opportunities.
Authors: Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Diseases
Source: Cancer Research Institute/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023